Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases

Figure 1

Serum SPINK1 levels in patients infected with HBV and healthy control participants detected by ELISA. (a) Comparison of serum SPINK1 levels between patients infected with HBV and healthy controls by ELISA. (b) Comparison of serum SPINK1 levels between patients testing positive and those testing negative for HBeAg. (c) Comparison of serum SPINK1 levels among patients with CHB, LC, or HCC. Box plots show medians with 25 and 75% and whiskers with 5 and 95% percentiles. indicates P<0.05.

(a)

(b)

(c)